Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
dc.contributor.author | Balcells, María Elvira | |
dc.contributor.author | Rojas, Luis | |
dc.contributor.author | Le Corre, Nicole | |
dc.contributor.author | Martínez-Valdebenito, Constanza | |
dc.contributor.author | Ceballos, María Elena | |
dc.contributor.author | Ferrés, Marcela | |
dc.contributor.author | Chang, Mayling | |
dc.contributor.author | Vizcaya, Cecilia | |
dc.contributor.author | Mondaca, Sebastián | |
dc.contributor.author | Huete, Álvaro | |
dc.contributor.author | Castro, Ricardo | |
dc.contributor.author | Sarmiento, Mauricio | |
dc.contributor.author | Villarroel, Luis | |
dc.contributor.author | Pizarro, Alejandra | |
dc.contributor.author | Ross, Patricio | |
dc.contributor.author | Santander, Jaime | |
dc.contributor.author | Lara, Barbara | |
dc.contributor.author | Ferrada, Marcela | |
dc.contributor.author | Vargas-Salas, Sergio | |
dc.contributor.author | Beltrán-Pavez, Carolina | |
dc.contributor.author | Soto-Rifo, Ricardo | |
dc.contributor.author | Valiente-Echeverría, Fernando | |
dc.contributor.author | Caglevic, Christian | |
dc.contributor.author | Mahave, Mauricio | |
dc.contributor.author | Selman, Carolina | |
dc.contributor.author | Gazitúa, Raimundo | |
dc.contributor.author | Briones, José Luis | |
dc.contributor.author | Villarroel-Espindola, Franz | |
dc.contributor.author | Balmaceda, Carlos | |
dc.contributor.author | Espinoza, Manuel A. | |
dc.contributor.author | Pereira, Jaime | |
dc.contributor.author | Nervi, Bruno | |
dc.date.accessioned | 2023-05-19T20:46:35Z | |
dc.date.available | 2023-05-19T20:46:35Z | |
dc.date.issued | 2020 | |
dc.fechaingreso.objetodigital | 2025-04-25 | |
dc.fuente.origen | ORCID-mayo23 | |
dc.identifier.doi | 10.1101/2020.09.17.20196212 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/69819 | |
dc.language.iso | en | |
dc.nota.acceso | contenido completo | |
dc.rights | acceso abierto | |
dc.title | Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial | es_ES |
dc.type | otro |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19 A Randomized Phase II Clinical Trial.pdf
- Size:
- 1.05 MB
- Format:
- Adobe Portable Document Format
- Description: